We are live on ! Find out more
Crestline Management

Crestline Management Portfolio holdings

AUM $29.3M Turnover 33.33%
1-Year Est. Return 36.29%
This Fund
S&P 500
This Quarter Est. Return
+25.68%
1 Year Est. Return
+36.29%
3 Year Est. Return
+56.08%
5 Year Est. Return
+35.53%
10 Year Est. Return
+400.77%
AUM
$746M
AUM Growth
+$200M
Cap. Flow
+$60.7M
Cap. Flow %
8.13%
Top 10 Hldgs %
76.52%
Holding
190
New
78
Increased
30
Reduced
20
Closed
61
Avg Time Held Equity + Options
0.2 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.2 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
MON
Monsanto
MON
+$6.18M
2
VRSK icon
Verisk Analytics
VRSK
+$5.61M
3
APD icon
Air Products & Chemicals
APD
+$4.62M
4
DNB icon
Dun & Bradstreet
DNB
+$4.57M
5
HON icon
Honeywell
HON
+$4.05M

Top Sells

Rank Stock Value
1
FNB icon
FNB
FNB
+$5.19M
2
DOV icon
Dover
DOV
+$4.9M
3
ASB icon
Associated Banc-Corp
ASB
+$3.9M
4
KEY icon
KeyCorp
KEY
+$3.73M
5
PACW
PacWest Bancorp
PACW
+$2.93M

Sector Composition

Rank Sector Weight
1 Healthcare 76.39%
2 Financials 12.59%
3 Industrials 5.43%
4 Materials 3.1%
5 Technology 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JUNO
1
DELISTED
Juno Therapeutics
JUNO
$520M 69.6%
17,382,192
+33,393
+0.2% +$824K
2014 Q4
10 quarters
RF icon
2
Regions Financial
RF
$23.2B
$6.59M 0.88%
450,000
+230,000
+105% +$3.24M
2016 Q4
2 quarters
CE icon
3
Celanese
CE
$5.2B
$6.41M 0.86%
67,500
+18,550
+38% +$1.65M
2017 Q1
1 quarter
MON
4
DELISTED
Monsanto
MON
$6.27M 0.84%
+53,000
New +$6.18M
2017 Q2
0 quarters
HON icon
5
Honeywell
HON
$69.1B
$6.26M 0.84%
52,029
+34,317
+194% +$4.05M
2017 Q1
1 quarter
BG icon
6
Bunge Global
BG
$17.6B
$5.97M 0.8%
80,000
+27,600
+53% +$2.1M
2017 Q1
1 quarter
VRSK icon
7
Verisk Analytics
VRSK
$25.7B
$5.84M 0.78%
+69,264
New +$5.61M
2017 Q2
0 quarters
WCN icon
8
Waste Connections
WCN
$45.1B
$4.99M 0.67%
77,500
+9,137
+13% +$568K
2017 Q1
1 quarter
APD icon
9
Air Products & Chemicals
APD
$67.7B
$4.65M 0.62%
+32,500
New +$4.62M
2017 Q2
0 quarters
DNB icon
10
DELISTED
Dun & Bradstreet
DNB
$4.61M 0.62%
+42,653
New +$4.57M
2017 Q2
0 quarters
FDX icon
11
FedEx
FDX
$73.7B
$4.46M 0.6%
20,500
-4,700
-19% -$928K
2017 Q1
1 quarter
STL
12
DELISTED
Sterling Bancorp
STL
$4.42M 0.59%
190,000
+150,000
+375% +$3.43M
2017 Q1
1 quarter
PB icon
13
Prosperity Bancshares
PB
$8.44B
$4.18M 0.56%
65,000
+48,000
+282% +$3.16M
2016 Q4
2 quarters
AJG icon
14
Arthur J. Gallagher & Co
AJG
$71.2B
$3.8M 0.51%
+66,345
New +$3.75M
2017 Q2
0 quarters
GILD icon
15
Gilead Sciences
GILD
$207B
$3.6M 0.48%
50,881
+28,881
+131% +$1.92M
2017 Q1
1 quarter
RGA icon
16
Reinsurance Group of America
RGA
$17.4B
$3.47M 0.46%
+27,029
New +$3.41M
2017 Q2
0 quarters
FIS icon
17
Fidelity National Information Services
FIS
$13.4B
$3.31M 0.44%
+38,730
New +$3.24M
2017 Q2
0 quarters
FDS icon
18
Factset
FDS
$10.9B
$3.26M 0.44%
+19,605
New +$3.21M
2017 Q2
0 quarters
LUV icon
19
Southwest Airlines
LUV
$22.3B
$3.23M 0.43%
52,000
+8,500
+20% +$495K
2017 Q1
1 quarter
PBCT
20
DELISTED
People's United Financial
PBCT
$3.09M 0.41%
175,000
+60,000
+52% +$1.04M
2016 Q4
2 quarters
TXCP icon
21
Texas Capital Bancshares
TXCP
$4.22B
$3.02M 0.4%
39,000
+29,000
+290% +$2.23M
2016 Q3
3 quarters
AMP icon
22
Ameriprise Financial
AMP
$42.7B
$2.97M 0.4%
+23,345
New +$2.96M
2017 Q2
0 quarters
TFC icon
23
Truist Financial
TFC
$55.9B
$2.82M 0.38%
62,000
-20,000
-24% -$868K
2016 Q4
2 quarters
WAL icon
24
Western Alliance Bancorporation
WAL
$7.49B
$2.76M 0.37%
56,000
+5,000
+10% +$238K
2016 Q4
2 quarters
AMG icon
25
Affiliated Managers Group
AMG
$9.34B
$2.66M 0.36%
+16,047
New +$2.56M
2017 Q2
0 quarters

Similar funds

Crestline Management's Q2 2017 Portfolio in Review

As of Q2 2017, Crestline Management held 190 positions worth $746M, up 37% from $546M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Crestline Management deployed $60.7M of net new capital in Q2 2017, opening 78 new positions and adding to 30 existing holdings. Its largest new stake was Monsanto: 53,000 shares worth $6.27M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 75% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was FNB, an estimated $5.19M trimmed.

  • Crestline Management's largest Q2 2017 buy was Monsanto: 53,000 shares worth $6.27M.
  • Crestline Management added most to Honeywell in Q2 2017, an estimated $4.05M increase.
  • Crestline Management's biggest Q2 2017 reduction was FNB, cutting an estimated $5.19M.
  • Crestline Management fully exited Dover in Q2 2017, selling an estimated $4.9M.
  • Crestline Management's ten largest holdings make up 77% of its $746M portfolio in Q2 2017.
  • Crestline Management opened 78 new positions and closed 61 in Q2 2017.
  • Crestline Management's portfolio value rose 37% quarter-over-quarter to $746M.

Based on Crestline Management's 13F filing for Q2 2017, filed 14 Aug 2017.